More than 133 million doses of coronavirus vaccines have been administered across 85 countrie, with a daily rate roughly 4.69 million doses a day. The U.S. has an established vaccine safety system that ensures all vaccines are as safe as possible. Since Dec. 14, 2020, the United States has shipped more than 45 million doses, from Pfizer-BioNTech and Moderna.
Approved/authorized vaccines
| Vaccine Name | Vaccine Type | Efficacy | Developers | Origin | Approval |
|---|---|---|---|---|---|
| COMIRNATY® (BNT162b2) | mRNA-based vaccine | 95% | Pfizer, BioNTech; Fosun Pharma | Multinational | Albania, Argentina, Australia, Bahrain, Canada, Chile, Colombia, Costa Rica, Ecuador, EU, Faroe Islands, Greenland, Iceland, Iraq, Israel, Jordan, Kuwait, Malaysia, Mexico, Norway, Oman, Panama, Philippines, Qatar, Saudi Arabia, Serbia, Singapore, Switzerland, Tunisia, UAE, U.K, U.S |
| AstraZeneca (AZD1222) | Adenovirus vaccine | 70% | AstraZeneca/Oxford University | UK | Argentina, Bahrain, Bangladesh, Brazil, Canada, Chile, Dominican Republic, Ecuador, El Salvador, EU, Hungary, India, Iraq, Mexico, Morocco, Myanmar, Nepal, Pakistan, Philippines, Saudi Arabia, South Africa, Sri Lanka, Thailand, Tunisia, UK, Vietnam |
| Sputnik V | Viral Vector | 92% | Russia’s Gamaleya Institute | Russie | Algeria, Argentina, Armenia, Belarus, Bolivia, Guinea, Hungary, Iran, Mexico, Pakistan, Palestine, Paraguay, Russia, Serbia, Tunisia, Turkmenistan, United Arab Emirates, Venezuela |
| CoronaVac | Inactivated vaccine | 51% | Chinese vaccine developer Sinovac | china |
Vaccine in development (Phase III)
| Candidate Vaccine | Vaccine Type | Development Phase | developers |
|---|---|---|---|
| Johnson & Johnson (JNJ-78436735) | Viral Vector | Phase 3 | Janssen Pharmaceutical Companies |
| Convidicea AD5-nCOV | Viral Vector | Phase 3 | Chinese biopharmaceutical company CanSino Biologics |
| NVX-CoV2373 | Nanoparticle Technology | Phase 3 | Novavax |
COVID-19 vaccine approved for use in UK
Pfizer, Moderna and Astrazeneca vaccine have been approved for emergency use in the UK and the US.
Pfizer and Moderna have both developed RNA vaccines, they inject a tiny fragment of the virus’s genetic code into the body, the molecule that cells naturally use to carry DNA’s instructions to cells’ protein-building machinery. However, Astrazeneca is a «viral vector» vaccine, uses a harmless virus to carry the same genetic material into our body. The order in which people will be offered the vaccine is based on advice from the Joint Committee on Vaccination and Immunisation
| Vaccine | Type | Dose | Storage |
|---|---|---|---|
| AstraZeneca/Oxford | Viral Vector | 2 | 2°C To 8°C |
| Pfizer/Biontech | RNA | 2 | -70°C |
| Moderna | RNA | 2 | -20°C |
COVID-19 Vaccines Authorized for Emergency Use in U.S
| Vaccine | Type | Dose | Storage |
|---|---|---|---|
| AstraZeneca/Oxford | Viral Vector | 2 | 2°C To 8°C |
| Pfizer/Biontech | RNA | 2 | -70°C |
| Moderna | RNA | 2 | -20°C |